March 19, 2020 / 12:32 PM / 21 days ago

BRIEF-Celsion Announces Highly Encouraging Initial Clinical Results From The Phase I Portion Of The Phase I/II Ovation 2 Study With Gen-1 In Patients With Advanced Ovarian Cancer

March 19 (Reuters) - Celsion Corp:

* CELSION ANNOUNCES HIGHLY ENCOURAGING INITIAL CLINICAL RESULTS FROM THE PHASE I PORTION OF THE PHASE I/II OVATION 2 STUDY WITH GEN-1 IN PATIENTS WITH ADVANCED OVARIAN CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below